NBA star Alonzo Mourning visits UCH to increase awareness of kidney disease

NBA star Alonzo Mourning visits UCH to increase awareness of kidney disease

March 20, 2003

When basketball superstar Alonzo Mourning was diagnosed with kidney disease more than two years ago, he faced the toughest challenge of his life. What he didn't realize was that he was facing two opponents: his kidney disease, and the debilitating anemia that often comes with chronic disease.

On March 26, Mourning will speak at the University of Chicago Hospitals about his personal experience with anemia, and its treatment. A free educational seminar about CKD will also be provided for all attendees. The event will take place from 12:30 - 2:00 p.m. on the 4th floor atrium of the Duchossois Center for Advanced Medicine.

The presentation is part of Rebound from Anemia, a national campaign to educate and motivate the millions of chronic kidney disease (CKD) patients at risk for anemia. Rebound from Anemia is sponsored by Ortho Biotech Products, L.P., marketer of PROCRIT® (Epoetin alfa) and supporter of Mourning's "Zo's Fund for Life."

"Once my doctor began treating my kidney disease, my greatest challenge was the constant exhaustion," said Mourning. "Fortunately, my doctor explained that anemia was causing my exhaustion, and that people with serious illnesses, like kidney disease, are at increased risk for anemia. He also explained that anemia was a treatable condition."

"It is important for people with chronic kidney disease to learn all they can about their healthcare," said Kris Robinson, executive director, American Association of Kidney Patients. "We hope this important campaign will encourage those with chronic kidney disease to learn about their disease, potential side-effects and treatment options."

Anemia is a potentially life-threatening condition that occurs when the body does not have enough red blood cells, which carry oxygen. Oxygen acts like fuel for the body, providing energy for muscles and organs to work. Common symptoms include extreme fatigue, shortness of breath, dizziness, decreased ability to concentrate and sleeplessness.